Skip to content Skip to footer

International Cannabis Weekly: 153

June 26, 2020

Highlights

Share this story
Highlights

Highlights

Share this story
Europe

Highlights

Share this story
PROHIBITION PARTNERS LIVE

 

 

Missed out on Prohibition Partners LIVE? Not to worry, you can access all 120 hours of virtual debate, market intelligence and consumer data via our on-demand platform.

We highly recommend watching Protecting the Consumer: CBD in Europe (Cannabis Europa), Building Successful Cannabis Brands (Cannabis Americana), and What Lies Ahead? The Future of Therapy (The PSYCH Symposium).

Access all the content now for 30 days for as little as $59 (£47/€53).

BUY NOW

Highlights

Share this story
USA

Highlights

Share this story
Canada

Highlights

Share this story
Latam & Caribbean

Highlights

Share this story
APAC

Highlights

Share this story
Africa & Middle East

Highlights

Share this story
Health & Science

Highlights

Share this story
Psychedelics

Highlights

Share this story
FEATURE

 

 

Health insurance cannabis sales in Germany soared in Q1 2020, reaching a new record high of almost €15 million in March, more than 50% above the €9.5m of a year before.

The exceptionally good results in March 2020 may reflect some patients redeeming their prescriptions earlier to cope with the COVID-19 crisis, similar to the stockpiling seen in North American markets during March.

Read the full analysis from Prohibition Partners here.

READ NOW

Latest Issues

254

253

252

251

250

249

Insights

On the global cannabis industry

International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 70,000+ subscribers.